glp 1 and kidney disease GLP-1 receptor agonists are increasingly used to treat type 2 diabetes obesity, and trials have shown reductions in cardiovascular risk and slowing of failure. Adverse events are mostly gastrointestinal GLP1 Receptor Agonists vs SGLT2-I

There is no well-established dosage

Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase

Whether starting your day or winding down in the evening, this shower cream helps set the tone for a refreshing self-care ritual

GHK-Cu acts as a copper-binding signalling peptide that modulates the expression of thousands of genes involved in collagen remodelling, antioxidant defence, and tissue repair

Preclinical work has demonstrated that activation of mu opioid receptors (MORs) is necessary, but not sufficient for ketamine to reduce depressive-like behaviors 17 , that ( S )-ketamine involves direct interactions with brain MORs at doses and concentrations relevant to its reinforcement and antidepressant-like efficacy 18 , and that -endorphin presence and opioid receptor activation in the mPFC may be required for ketamines antidepressant actions 19